The impact of including passive benefits in cost-effectiveness analysis: the case of automated external defibrillators on commercial aircraft.

OBJECTIVE Traditional cost-utility analysis assumes that all benefits from health-related interventions are captured by the quality-adjusted life-years (QALYs) gained by the few individuals whose outcome is improved by the intervention. However, it is possible that many individuals who do not directly benefit from an intervention receive utility, and therefore QALYs, because of the passive benefit (aka sense of security) provided by the existence of the intervention. The objective of this study was to evaluate the impact that varying quantities of passive benefit have on the cost-effectiveness of airline defibrillator programs. METHODS A decision analytic model with Markov processes was constructed to evaluate the cost-effectiveness of defibrillator deployment on domestic commercial passenger aircraft over 1 year. Airline passengers were assigned small incremental utility gains (.001-.01) during an estimated 3-hour flight to evaluate the impact of passive benefit on overall cost-effectiveness. RESULTS In the base case analysis with no allowance for passive benefit, the cost-effectiveness of airline automated external defibrillator deployment was US dollars 34000 per QALY gained. If 1% of all passengers received utility gain of.01, the cost-effectiveness declined to US dollars 30000. Cost-effectiveness was enhanced when the quantity of passive benefit was raised or the percentage of individuals receiving passive benefit increased. CONCLUSIONS Automated external defibrillator deployment on passenger aircraft is likely to be cost-effective. If a small percentage of airline passengers receive incremental utility gains from passive benefit of automated external defibrillator availability, the impact on overall cost-effectiveness may be substantial. Further research should attempt to clarify the magnitude and percentage of patients who receive passive benefit.

[1]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[2]  D K McKenas,et al.  Use of automated external defibrillators by a U.S. airline. , 2000, The New England journal of medicine.

[3]  B. Gage,et al.  The Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life , 1996 .

[4]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine , 1997 .

[5]  F Vinicor,et al.  The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.

[6]  M. Johannesson,et al.  Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  A. J. Mcadams,et al.  Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  D J Roe,et al.  Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model. , 1997, Circulation.

[9]  G. Sanders,et al.  Cost-effectiveness of automated external defibrillators on airlines. , 2001, JAMA.

[10]  R O Cummins,et al.  Frequency and types of medical emergencies among commercial air travelers. , 1989, JAMA.

[11]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[12]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[13]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[14]  David O. Meltzer,et al.  Accounting for future costs in medical cost-effectiveness analysis. , 1997 .

[15]  G. Torrance Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[16]  G. Lombardi,et al.  Outcome of Out-of-Hospital Cardiac Arrest in New York City: The Pre-Hospital Arrest Survival Evaluation (PHASE) Study , 1994 .

[17]  M. Simoons,et al.  Long-term survival after out-of-hospital cardiac arrest: an 8-year follow-up. , 1999, Resuscitation.

[18]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[19]  J. Unji Yamaguchi,et al.  Some reflections on IT , 2001, WUAUC'01.

[20]  David O. Meltzer,et al.  Editorial: Some reflections on cost‐effectiveness analysis , 1998 .

[21]  A I Mushlin,et al.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.

[22]  J S Geddes,et al.  An airline cardiac arrest program. , 1997, Circulation.

[23]  S M Cobbe,et al.  Survival of 1476 patients initially resuscitated from out of hospital cardiac arrest , 1996, BMJ.

[24]  Milton C. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996 .

[25]  G. Larsen,et al.  Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy , 2002, Circulation.

[26]  P. Wilson,et al.  Epidemiology of cardiovascular disease in the United States. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  Bruce Caldwell,et al.  Some Reflections onBeyond Positivism , 1985 .

[28]  M Johannesson,et al.  Some reflections on cost-effectiveness analysis. , 1998, Health economics.

[29]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[30]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[31]  J P Ornato,et al.  Potential cost-effectiveness of public access defibrillation in the United States. , 1998, Circulation.

[32]  A Laupacis,et al.  What is the quality of life for survivors of cardiac arrest? A prospective study. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[33]  G. Bardy,et al.  Comparison of naive sixth-grade children with trained professionals in the use of an automated external defibrillator. , 1999, Circulation.

[34]  R. Kerber,et al.  Efficacy of an automated external defibrillator in the management of out-of-hospital cardiac arrest: validation of the diagnostic algorithm and initial clinical experience in a rural environment. , 1986, Circulation.

[35]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[36]  J. Bachman,et al.  A study of out-of-hospital cardiac arrests in northeastern Minnesota. , 1986, JAMA.

[37]  M. Weinstein,et al.  Theoretical issues in cost-effectiveness analysis. , 1997, Journal of health economics.

[38]  Lance B Becker,et al.  Public use of automated external defibrillators. , 2002, The New England journal of medicine.